Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 19805-19830

  Sharma, Ashish R ^a   Jagga, Supriya ^a   Lee, Sang Soo ^a   Nam, Ju Suk ^a  

^a Hallym University   (South Korea)

Author keywords

Bone morphogenic protein (BMP); Cartilage; Mitogen activated protein kinases (MAPKs); Osteoarthritis; Subchondral bone; Wingless type (WNT)

Indexed keywords

AGGRECAN; AGGRECANASE 1; ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHONDROITIN SULFATE; COLLAGEN TYPE 2; COLLAGENASE 3; FIBRONECTIN; HYALURONIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; PROCOLLAGEN N PROTEINASE; PROSTAGLANDIN; PYRIDINOLINE; SCATTER FACTOR; SOMATOMEDIN C; SPHINGOSINE 1 PHOSPHATE; TRANSCRIPTION FACTOR RUNX2; UROKINASE; VASCULOTROPIN; WNT PROTEIN;

BIOMECHANICS; BONE TURNOVER; CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL COMMUNICATION; CORTICAL BONE; DISEASE COURSE; DISEASE SEVERITY; EXTRACELLULAR MATRIX; GENETIC POLYMORPHISM; HOMEOSTASIS; HUMAN; IMMUNOREACTIVITY; MINERALIZATION; MOLECULAR INTERACTION; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; OSTEOLYSIS; OSTEOSCLEROSIS; PATHOGENESIS; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SUBCHONDRAL BONE PLATE; SYNOVIAL FLUID; SYNOVIUM; VASCULARIZATION; WNT SIGNALING PATHWAY;

ANIMALS; BONE AND BONES; CARTILAGE; CHONDROCYTES; HUMANS; OSTEOARTHRITIS; OSTEOBLASTS; SIGNAL TRANSDUCTION;

EID: 84885140804     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141019805     Document Type: Review

References (134)

1. Castaneda, S.; Roman-Blas, J.A.; Largo, R.; Herrero-Beaumont, G. Subchondral bone as a key target for osteoarthritis treatment. Biochem. Pharmacol. 2012, 83, 315-323.
2. Lawrence, R.C.; Felson, D.T.; Helmick, C.G.; Arnold, L.M.; Choi, H.; Deyo, R.A.; Gabriel, S.; Hirsch, R.; Hochberg, M.C.; Hunder, G.G.; et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008, 58, 26-35.
3. Lawrence, J.S.; Bremner, J.M.; Bier, F. Osteo-arthrosis. Prevalence in the population and relationship between symptoms and X-ray changes. Ann. Rheum. Dis. 1966, 25, 1-24.
4. Felson, D.T. Clinical practice. Osteoarthritis of the knee. N. Engl. J. Med. 2006, 354, 841-848.
5. Felson, D.T.; Anderson, J.J.; Meenan, R.F. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum. 1990, 33, 1449-1461.
6. Roos, E.M. Joint injury causes knee osteoarthritis in young adults. Curr. Opin. Rheumatol. 2005, 17, 195-200.
7. Brandt, K.D.; Radin, E.L.; Dieppe, P.A.; van de Putte, L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann. Rheum. Dis. 2006, 65, 1261-1264.
8. Kwan Tat, S.; Lajeunesse, D.; Pelletier, J.P.; Martel-Pelletier, J. Targeting subchondral bone for treating osteoarthritis: What is the evidence? Best Pract. Res. Clin. Rheumatol. 2010, 24, 51-70.
9. Karsdal, M.A.; Leeming, D.J.; Dam, E.B.; Henriksen, K.; Alexandersen, P.; Pastoureau, P.; Altman, R.D.; Christiansen, C. Should subchondral bone turnover be targeted when treating osteoarthritis? Osteoarthr. Cartil. 2008, 16, 638-646.
10. Wan, R.; Hu, J.; Zhou, Q.; Wang, J.; Liu, P.; Wei, Y. Application of co-expressed genes to articular cartilage: New hope for the treatment of osteoarthritis (review). Mol. Med. Rep. 2012, 6, 16-18.
11. Ansboro, S.; Greiser, U.; Barry, F.; Murphy, M. Strategies for improved targeting of therapeutic cells: Implications for tissue repair. Eur. Cells Mater. 2012, 23, 310-319.
12. Burr, D.B. The importance of subchondral bone in osteoarthrosis. Curr. Opin. Rheumatol. 1998, 10, 256-262.
13. Bailey, A.J.; Mansell, J.P. Do subchondral bone changes exacerbate or precede articular cartilage destruction in osteoarthritis of the elderly? Gerontology 1997, 43, 296-304.
14. Clouet, J.; Vinatier, C.; Merceron, C.; Pot-vaucel, M.; Maugars, Y.; Weiss, P.; Grimandi, G.; Guicheux, J. From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov. Today 2009, 14, 913-925.
15. Poole, A.R.; Kojima, T.; Yasuda, T.; Mwale, F.; Kobayashi, M.; Laverty, S. Composition and structure of articular cartilage: A template for tissue repair. Clin. Orthop. Relat. Res. 2001, 391, S26-S33.
16. Burr, D.B. Anatomy and physiology of the mineralized tissues: Role in the pathogenesis of osteoarthrosis. Osteoarthr. Cartil. 2004, 12, S20-S30.
17. Servier Medical Art. Available online: http://www.servier.com/slidekit/?item=2 (accessed on 28 August 2013).
18. Guilak, F. Biomechanical factors in osteoarthritis. Best Pract. Res. Clin. Rheumatol. 2011, 25, 815-823.
19. Hunter, D.J.; Felson, D.T. Osteoarthritis. BMJ 2006, 332, 639-642.
20. Guilak, F.; Fermor, B.; Keefe, F.J.; Kraus, V.B.; Olson, S.A.; Pisetsky, D.S.; Setton, L.A.; Weinberg, J.B. The role of biomechanics and inflammation in cartilage injury and repair. Clin. Orthop. Relat. Res. 2004, 423, 17-26.
21. Burr, D.B.; Gallant, M.A. Bone remodelling in osteoarthritis. Nat. Rev. Rheumatol. 2012, 8, 665-673.
22. Goldring, M.B.; Goldring, S.R. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann. N. Y. Acad. Sci. 2010, 1192, 230-237.
23. Grimshaw, M.J.; Mason, R.M. Bovine articular chondrocyte function in vitro depends upon oxygen tension. Osteoarthr. Cartil. 2000, 8, 386-392.
24. Goldring, M.B.; Marcu, K.B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res. Ther. 2009, 11, 224.
25. Pulai, J.I.; Chen, H.; Im, H.J.; Kumar, S.; Hanning, C.; Hegde, P.S.; Loeser, R.F. NF-κB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J. Immunol. 2005, 174, 5781-5788.
26. Floman, Y.; Eyre, D.R.; Glimcher, M.J. Induction of osteoarthrosis in the rabbit knee joint: Biochemical studies on the articular cartilage. Clin. Orthop. Relat. Res. 1980, 147, 278-286.
27. Eyre, D.R.; McDevitt, C.A.; Billingham, M.E.; Muir, H. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem. J. 1980, 188, 823-837.
28. Kraus, V.B.; Burnett, B.; Coindreau, J.; Cottrell, S.; Eyre, D.; Gendreau, M.; Gardiner, J.; Garnero, P.; Hardin, J.; Henrotin, Y.; et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthr. Cartil. 2011, 19, 515-542.
29. Rousseau, J.; Garnero, P. Biological markers in osteoarthritis. Bone 2012, 51, 265-277.
30. Henrotin, Y.; Chevalier, X.; Deberg, M.; Balblanc, J.C.; Richette, P.; Mulleman, D.; Maillet, B.; Rannou, F.; Piroth, C.; Mathieu, P.; et al. Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO2) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: A research study part of the Biovisco study. J. Orthop. Res. 2013, 31, 901-907.
31. Nemirovskiy, O.V.; Sunyer, T.; Aggarwal, P.; Abrams, M.; Hellio Le Graverand, M.P.; Mathews, W.R. Discovery and development of the N-terminal procollagen type II (NPII) biomarker: A tool for measuring collagen type II synthesis. Osteoarthr. Cartil. 2008, 16, 1494-1500.
32. Lorenz, H.; Wenz, W.; Ivancic, M.; Steck, E.; Richter, W. Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res. Ther. 2005, 7, R156-R165.
33. Matyas, J.R.; Atley, L.; Ionescu, M.; Eyre, D.R.; Poole, A.R. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum. 2004, 50, 543-552.
34. Pavelka, K.; Forejtova, S.; Olejarova, M.; Gatterova, J.; Senolt, L.; Spacek, P.; Braun, M.; Hulejova, M.; Stovickova, J.; Pavelkova, A. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthr. Cartil. 2004, 12, 277-283.
35. Bettica, P.; Cline, G.; Hart, D.J.; Meyer, J.; Spector, T.D. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: Longitudinal results from the Chingford study. Arthritis Rheum. 2002, 46, 3178-3184.
36. Seibel, M.J. Biochemical markers of bone turnover. Part I: Biochemistry and variability. Clin. Biochem. Rev. 2005, 26, 97-122.
37. Senolt, L.; Pavelka, K. Molecular markers of osteoarthritis (in Czech). Acta Chir. Orthop. Traumatol. Cech. 2005, 72, 191-196.
38. Buckland-Wright, C. Subchondral bone changes in hand and knee osteoarthritis detected by radiography. Osteoarthr. Cartil. 2004, 12, S10-S19.
39. Thambyah, A.; Broom, N. On new bone formation in the pre-osteoarthritic joint. Osteoarthr. Cartil. 2009, 17, 456-463.
40. Brown, T.D.; Vrahas, M.S. The apparent elastic modulus of the juxtarticular subchondral bone of the femoral head. J. Orthop. Res. 1984, 2, 32-38.
41. Brandt, K.D.; Myers, S.L.; Burr, D.; Albrecht, M. Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament. Arthritis Rheum. 1991, 34, 1560-1570.
42. Dedrick, D.K.; Goldstein, S.A.; Brandt, K.D.; O'Connor, B.L.; Goulet, R.W.; Albrecht, M. A longitudinal study of subchondral plate and trabecular bone in cruciate-deficient dogs with osteoarthritis followed up for 54 months. Arthritis Rheum. 1993, 36, 1460-1467.
43. Burr, D.B.; Schaffler, M.B. The involvement of subchondral mineralized tissues in osteoarthrosis: Quantitative microscopic evidence. Microsc. Res. Tech. 1997, 37, 343-357.
44. Bailey, A.J.; Mansell, J.P.; Sims, T.J.; Banse, X. Biochemical and mechanical properties of subchondral bone in osteoarthritis. Biorheology 2004, 41, 349-358.
45. Sanchez, C.; Deberg, M.A.; Bellahcene, A.; Castronovo, V.; Msika, P.; Delcour, J.P.; Crielaard, J.M.; Henrotin, Y.E. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum. 2008, 58, 442-455.
46. Truong, L.H.; Kuliwaba, J.S.; Tsangari, H.; Fazzalari, N.L. Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients. Arthritis Res. Ther. 2006, 8, R188:1-R188:12.
47. Hilal, G.; Martel-Pelletier, J.; Pelletier, J.P.; Ranger, P.; Lajeunesse, D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: Possible role in subchondral bone sclerosis. Arthritis Rheum. 1998, 41, 891-899.
48. Day, J.S.; Ding, M.; van der Linden, J.C.; Hvid, I.; Sumner, D.R.; Weinans, H. A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage. J. Orthop. Res. 2001, 19, 914-918.
49. Burr, D.B.; Radin, E.L. Microfractures and microcracks in subchondral bone: Are they relevant to osteoarthrosis? Rheum. Dis. Clin. N. Am. 2003, 29, 675-685.
50. Lajeunesse, D.; Reboul, P. Subchondral bone in osteoarthritis: A biologic link with articular cartilage leading to abnormal remodeling. Curr. Opin. Rheumatol. 2003, 15, 628-633.
51. Westacott, C.I.; Webb, G.R.; Warnock, M.G.; Sims, J.V.; Elson, C.J. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum. 1997, 40, 1282-1291.
52. Imhof, H.; Breitenseher, M.; Kainberger, F.; Rand, T.; Trattnig, S. Importance of subchondral bone to articular cartilage in health and disease. Top. Magn. Reson. Imaging 1999, 10, 180-192.
53. Malinin, T.; Ouellette, E.A. Articular cartilage nutrition is mediated by subchondral bone: A long-term autograft study in baboons. Osteoarthr. Cartil. 2000, 8, 483-491.
54. Amin, A.K.; Huntley, J.S.; Simpson, A.H.; Hall, A.C. Chondrocyte survival in articular cartilage: The influence of subchondral bone in a bovine model. J. Bone Joint Surg. Br. Vol. 2009, 91, 691-699.
55. Jiao, K.; Niu, L.N.; Wang, M.Q.; Dai, J.; Yu, S.B.; Liu, X.D.; Wang, J. Subchondral bone loss following orthodontically induced cartilage degradation in the mandibular condyles of rats. Bone 2011, 48, 362-371.
56. Johnstone, E.W.; Leane, P.B.; Byers, S.; Hopwood, J.J.; Foster, B.K. Metaphyseal factors promote calcium incorporation in physeal chondrocyte cultures. J. Orthop. Sci. 2000, 5, 593-599.
57. Moreno-Rubio, J.; Herrero-Beaumont, G.; Tardio, L.; Alvarez-Soria, M.A.; Largo, R. Nonsteroidal antiinflammatory drugs and prostaglandin E2 modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis. Arthritis Rheum. 2010, 62, 478-488.
58. Nurminskaya, M.; Magee, C.; Faverman, L.; Linsenmayer, T.F. Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periosteal bone. Dev. Biol. 2003, 263, 139-152.
59. Benito, M.J.; Veale, D.J.; FitzGerald, O.; van den Berg, W.B.; Bresnihan, B. Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 2005, 64, 1263-1267.
60. Loeser, R.F. Molecular mechanisms of cartilage destruction: Mechanics, inflammatory mediators, and aging collide. Arthritis Rheum. 2006, 54, 1357-1360.
61. Brown, R.A.; Tomlinson, I.W.; Hill, C.R.; Weiss, J.B.; Phillips, P.; Kumar, S. Relationship of angiogenesis factor in synovial fluid to various joint diseases. Ann. Rheum. Dis. 1983, 42, 301-307.
62. Sanchez, C.; Deberg, M.A.; Piccardi, N.; Msika, P.; Reginster, J.Y.; Henrotin, Y.E. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6,-1β and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthr. Cartil. 2005, 13, 979-987.
63. Botter, S.M.; Glasson, S.S.; Hopkins, B.; Clockaerts, S.; Weinans, H.; van Leeuwen, J.P.; van Osch, G.J. ADAMTS5-/-mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: Implications for a link between cartilage and subchondral bone changes. Osteoarthr. Cartil. 2009, 17, 636-645.
64. Mansell, J.P.; Collins, C.; Bailey, A.J. Bone, not cartilage, should be the major focus in osteoarthritis. Nat. Clin. Pract. Rheumatol. 2007, 3, 306-307.
65. Upton, A.R.; Holding, C.A.; Dharmapatni, A.A.; Haynes, D.R. The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. Rheumatol. Int. 2012, 32, 535-540.
66. Martinez-Calatrava, M.J.; Prieto-Potin, I.; Roman-Blas, J.A.; Tardio, L.; Largo, R.; Herrero-Beaumont, G. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. Arthritis Res. Ther. 2012, 14, R149:1-R149:13.
67. Sanchez, C.; Deberg, M.A.; Piccardi, N.; Msika, P.; Reginster, J.Y.; Henrotin, Y.E. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthr. Cartil. 2005, 13, 988-997.
68. Mansell, J.P.; Bailey, A.J. Abnormal cancellous bone collagen metabolism in osteoarthritis. J. Clin. Investig. 1998, 101, 1596-603.
69. Bellido, M.; Lugo, L.; Roman-Blas, J.A.; Castaneda, S.; Caeiro, J.R.; Dapia, S.; Calvo, E.; Largo, R.; Herrero-Beaumont, G. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res. Ther. 2010, 12, R152:1-R152:11.
70. Boyle, W.J.; Simonet, W.S.; Lacey, D.L. Osteoclast differentiation and activation. Nature 2003, 423, 337-342.
71. Hayami, T.; Pickarski, M.; Zhuo, Y.; Wesolowski, G.A.; Rodan, G.A.; Duong le, T. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 2006, 38, 234-243.
72. Hayami, T.; Pickarski, M.; Wesolowski, G.A.; McLane, J.; Bone, A.; Destefano, J.; Rodan, G.A.; Duong le, T. The role of subchondral bone remodeling in osteoarthritis: Reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum. 2004, 50, 1193-1206.
73. Schett, G.; Stolina, M.; Bolon, B.; Middleton, S.; Adlam, M.; Brown, H.; Zhu, L.; Feige, U.; Zack, D.J. Analysis of the kinetics of osteoclastogenesis in arthritic rats. Arthritis Rheum. 2005, 52, 3192-3201.
74. Stolina, M.; Adamu, S.; Ominsky, M.; Dwyer, D.; Asuncion, F.; Geng, Z.; Middleton, S.; Brown, H.; Pretorius, J.; Schett, G.; et al. RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis. J. Bone Miner. Res. 2005, 20, 1756-1765.
75. Blanquaert, F.; Pereira, R.C.; Canalis, E. Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts. Am. J. Physiol. Endocrinol. Metab. 2000, 278, E509-E515.
76. Guevremont, M.; Martel-Pelletier, J.; Massicotte, F.; Tardif, G.; Pelletier, J.P.; Ranger, P.; Lajeunesse, D.; Reboul, P. Human adult chondrocytes express hepatocyte growth factor (HGF) isoforms but not HgF: Potential implication of osteoblasts on the presence of HGF in cartilage. J. Bone Miner. Res. 2003, 18, 1073-1081.
77. Moldovan, F.; Pelletier, J.P.; Hambor, J.; Cloutier, J.M.; Martel-Pelletier, J. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: In vitro mimicking effect by transforming growth factor β. Arthritis Rheum. 1997, 40, 1653-1661.
78. Moon, M.H.; Jeong, J.K.; Lee, Y.J.; Seol, J.W.; Park, S.Y. Sphingosine-1-phosphate inhibits interleukin-1β-induced inflammation in human articular chondrocytes. Int. J. Mol. Med. 2012, 30, 1451-1458.
79. Masuko, K.; Murata, M.; Beppu, M.; Nakamura, H.; Kato, T.; Yudoh, K. Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: A possible new role in arthritis. Int. J. Rheum. Dis. 2012, 15, 366-373.
80. Lories, R.J.; Luyten, F.P. The bone-cartilage unit in osteoarthritis. Nat. Rev. Rheumatol. 2011, 7, 43-49.
81. Logan, C.Y.; Nusse, R. The WNT signaling pathway in development and disease. Ann. Rev. Cell Dev. Biol. 2004, 20, 781-810.
82. MacDonald, B.T.; Tamai, K.; He, X. WNT/β-catenin signaling: Components, mechanisms, and diseases. Dev. Cell 2009, 17, 9-26.
83. Hall, C.L.; Kang, S.; MacDougald, O.A.; Keller, E.T. Role of WNTs in prostate cancer bone metastases. J. Cell. Biochem. 2006, 97, 661-672.
84. Lodewyckx, L.; Lories, R.J. WNT signaling in osteoarthritis and osteoporosis: What is the biological significance for the clinician? Curr. Rheumatol. Rep. 2009, 11, 23-30.
85. Zhu, M.; Tang, D.; Wu, Q.; Hao, S.; Chen, M.; Xie, C.; Rosier, R.N.; O'Keefe, R.J.; Zuscik, M.; Chen, D. Activation of β-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult β-catenin conditional activation mice. J. Bone Miner. Res. 2009, 24, 12-21.
86. Zhu, M.; Chen, M.; Zuscik, M.; Wu, Q.; Wang, Y.J.; Rosier, R.N.; O'Keefe, R.J.; Chen, D. Inhibition of β-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum. 2008, 58, 2053-2064.
87. Lodewyckx, L.; Luyten, F.P.; Lories, R.J. Genetic deletion of low-density lipoprotein receptor-related protein 5 increases cartilage degradation in instability-induced osteoarthritis. Rheumatology 2012, 51, 1973-1978.
88. Hoang, B.; Moos, M., Jr.; Vukicevic, S.; Luyten, F.P. Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J. Biol. Chem. 1996, 271, 26131-26137.
89. Lories, R.J.; Peeters, J.; Bakker, A.; Tylzanowski, P.; Derese, I.; Schrooten, J.; Thomas, J.T.; Luyten, F.P. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 2007, 56, 4095-4103.
90. Nalesso, G.; Sherwood, J.; Bertrand, J.; Pap, T.; Ramachandran, M.; de Bari, C.; Pitzalis, C.; Dell'accio, F. WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways. J. Cell Biol. 2011, 193, 551-564.
91. Ryu, J.H.; Chun, J.S. Opposing roles of WNT-5A and WNT-11 in interleukin-1beta regulation of type II collagen expression in articular chondrocytes. J. Biol. Chem. 2006, 281, 22039-22047.
92. Church, V.; Nohno, T.; Linker, C.; Marcelle, C.; Francis-West, P. WNT regulation of chondrocyte differentiation. J. Cell Sci. 2002, 115, 4809-4818.
93. Baron, R.; Kneissel, M. WNT signaling in bone homeostasis and disease: From human mutations to treatments. Nat. Med. 2013, 19, 179-192.
94. Jenkins, Z.A.; van Kogelenberg, M.; Morgan, T.; Jeffs, A.; Fukuzawa, R.; Pearl, E.; Thaller, C.; Hing, A.V.; Porteous, M.E.; Garcia-Minaur, S.; et al. Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat. Genet. 2009, 41, 95-100.
95. Lyons, T.J.; McClure, S.F.; Stoddart, R.W.; McClure, J. The normal human chondro-osseous junctional region: Evidence for contact of uncalcified cartilage with subchondral bone and marrow spaces. BMC Musculoskelet. Disord. 2006, 7, 52:1-52:8.
96. Chan, B.Y.; Fuller, E.S.; Russell, A.K.; Smith, S.M.; Smith, M.M.; Jackson, M.T.; Cake, M.A.; Read, R.A.; Bateman, J.F.; Sambrook, P.N.; et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthr. Cartil. 2011, 19, 874-885.
97. Leijten, J.C.; Emons, J.; Sticht, C.; van Gool, S.; Decker, E.; Uitterlinden, A.; Rappold, G.; Hofman, A.; Rivadeneira, F.; Scherjon, S.; et al. Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum. 2012, 64, 3302-3312.
98. Ijiri, K.; Nagayoshi, R.; Matsushita, N.; Tsuruga, H.; Taniguchi, N.; Gushi, A.; Sakakima, H.; Komiya, S.; Matsuyama, T. Differential expression patterns of secreted frizzled related protein genes in synovial cells from patients with arthritis. J. Rheumatol. 2002, 29, 2266-2270.
99. Weng, L.H.; Wang, C.J.; Ko, J.Y.; Sun, Y.C.; Wang, F.S. Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees. Arthritis Rheum. 2010, 62, 1393-1402.
100. Dell'accio, F.; de Bari, C.; Eltawil, N.M.; Vanhummelen, P.; Pitzalis, C. Identification of the molecular response of articular cartilage to injury, by microarray screening: WNT-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum. 2008, 58, 1410-1421.
101. Blom, A.B.; Brockbank, S.M.; van Lent, P.L.; van Beuningen, H.M.; Geurts, J.; Takahashi, N.; van der Kraan, P.M.; van de Loo, F.A.; Schreurs, B.W.; Clements, K.; et al. Involvement of the WNT signaling pathway in experimental and human osteoarthritis: Prominent role of WNT-induced signaling protein 1. Arthritis Rheum. 2009, 60, 501-512.
102. Kuliwaba, J.S.; Findlay, D.M.; Atkins, G.J.; Forwood, M.R.; Fazzalari, N.L. Enhanced expression of osteocalcin mRNA in human osteoarthritic trabecular bone of the proximal femur is associated with decreased expression of interleukin-6 and interleukin-11 mRNA. J. Bone Miner. Res. 2000, 15, 332-341.
103. Golovchenko, S.; Hattori, T.; Hartmann, C.; Gebhardt, M.; Gebhard, S.; Hess, A.; Pausch, F.; Schlund, B.; von der Mark, K. Deletion of beta catenin in hypertrophic growth plate chondrocytes impairs trabecular bone formation. Bone 2013, 55, 102-112.
104. Blaney Davidson, E.N.; van der Kraan, P.M.; van den Berg, W.B. TGF-β and osteoarthritis. Osteoarthr. Cartil. 2007, 15, 597-604.
105. Goldring, M.B.; Tsuchimochi, K.; Ijiri, K. The control of chondrogenesis. J. Cell. Biochem. 2006, 97, 33-44.
106. Zhao, L.; Li, G.; Zhou, G.Q. SOX9 directly binds CREB as a novel synergism with the PKA pathway in BMP-2-induced osteochondrogenic differentiation. J. Bone Miner. Res. 2009, 24, 826-836.
107. Retting, K.N.; Song, B.; Yoon, B.S.; Lyons, K.M. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 2009, 136, 1093-1104.
108. Chen, A.L.; Fang, C.; Liu, C.; Leslie, M.P.; Chang, E.; Di Cesare, P.E. Expression of bone morphogenetic proteins, receptors, and tissue inhibitors in human fetal, adult, and osteoarthritic articular cartilage. J. Orthop. Res. 2004, 22, 1188-1192.
109. Blaney Davidson, E.N.; Vitters, E.L.; van Lent, P.L.; van de Loo, F.A.; van den Berg, W.B.; van der Kraan, P.M. Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling. Arthritis Res. Ther. 2007, 9, R102:1-R102:11.
110. Lories, R.J.; Daans, M.; Derese, I.; Matthys, P.; Kasran, A.; Tylzanowski, P.; Ceuppens, J.L.; Luyten, F.P. Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum. 2006, 54, 1736-1746.
111. Wu, X.; Shi, W.; Cao, X. Multiplicity of BMP signaling in skeletal development. Ann. N. Y. Acad. Sci. 2007, 1116, 29-49.
112. Tchetina, E.V.; Squires, G.; Poole, A.R. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J. Rheumatol. 2005, 32, 876-886.
113. Horiki, M.; Imamura, T.; Okamoto, M.; Hayashi, M.; Murai, J.; Myoui, A.; Ochi, T.; Miyazono, K.; Yoshikawa, H.; Tsumaki, N. Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia. J. Cell Biol. 2004, 165, 433-445.
114. Van der Kraan, P.M.; Blaney Davidson, E.N.; van den Berg, W.B. Bone morphogenetic proteins and articular cartilage: To serve and protect or a wolf in sheep clothing's? Osteoarthr. Cartil. 2010, 18, 735-741.
115. Yamaguchi, A.; Komori, T.; Suda, T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 2000, 21, 393-411.
116. Daans, M.; Luyten, F.P.; Lories, R.J. GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann. Rheum. Dis. 2011, 70, 208-213.
117. Yang, X.; Chen, L.; Xu, X.; Li, C.; Huang, C.; Deng, C.X. TGF-β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol. 2001, 153, 35-46.
118. Scharstuhl, A.; Glansbeek, H.L.; van Beuningen, H.M.; Vitters, E.L.; van der Kraan, P.M.; van den Berg, W.B. Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J. Immunol. 2002, 169, 507-514.
119. Scharstuhl, A.; Vitters, E.L.; van der Kraan, P.M.; van den Berg, W.B. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum. 2003, 48, 3442-3451.
120. Tang, Y.; Wu, X.; Lei, W.; Pang, L.; Wan, C.; Shi, Z.; Zhao, L.; Nagy, T.R.; Peng, X.; Hu, J.; et al. TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 2009, 15, 757-765.
121. Zhen, G.; Wen, C.; Jia, X.; Li, Y.; Crane, J.L.; Mears, S.C.; Askin, F.B.; Frassica, F.J.; Chang, W.; Yao, J.; et al. Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat. Med. 2013, 19, 704-712.
122. Tardif, G.; Pelletier, J.P.; Boileau, C.; Martel-Pelletier, J. The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: An immunohistochemical study. Osteoarthr. Cartil. 2009, 17, 263-270.
123. Inkson, C.A.; Ono, M.; Kuznetsov, S.A.; Fisher, L.W.; Robey, P.G.; Young, M.F. TGF-β1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J. Cell. Biochem. 2008, 104, 1865-1878.
124. Oh, C.D.; Chang, S.H.; Yoon, Y.M.; Lee, S.J.; Lee, Y.S.; Kang, S.S.; Chun, J.S. Opposing role of mitogen-activated protein kinase subtypes, ERK-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J. Biol. Chem. 2000, 275, 5613-5619.
125. Stanton, L.A.; Underhill, T.M.; Beier, F. MAP kinases in chondrocyte differentiation. Dev. Biol. 2003, 263, 165-175.
126. Greenblatt, M.B.; Shim, J.H.; Glimcher, L.H. Mitogen-activated protein kinase pathways in osteoblasts. Annu. Rev. Cell Dev. Biol. 2013, doi:10.1146/annurev-cellbio-101512-122347.
127. Sondergaard, B.C.; Schultz, N.; Madsen, S.H.; Bay-Jensen, A.C.; Kassem, M.; Karsdal, M.A. MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation-divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation. Osteoarthr. Cartil. 2010, 18, 279-288.
128. Yang, C.M.; Chien, C.S.; Yao, C.C.; Hsiao, L.D.; Huang, Y.C.; Wu, C.B. Mechanical strain induces collagenase-3 (MMP-13) expression in MC3T3-E1 osteoblastic cells. J. Biol. Chem. 2004, 279, 22158-22165.
129. Prasadam, I.; Friis, T.; Shi, W.; van Gennip, S.; Crawford, R.; Xiao, Y. Osteoarthritic cartilage chondrocytes alter subchondral bone osteoblast differentiation via MAPK signalling pathway involving ERK1/2. Bone 2010, 46, 226-235.
130. Prasadam, I.; van Gennip, S.; Friis, T.; Shi, W.; Crawford, R.; Xiao, Y. ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. Arthritis Rheum. 2010, 62, 1349-1360.
131. Prasadam, I.; Crawford, R.; Xiao, Y. Aggravation of ADAMTS and matrix metalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes-Possible pathogenic role in osteoarthritis. J. Rheumatol. 2012, 39, 621-634.
132. Hollenberg, M.D.; Compton, S.J. International union of pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol. Rev. 2002, 54, 203-217.
133. Boileau, C.; Amiable, N.; Martel-Pelletier, J.; Fahmi, H.; Duval, N.; Pelletier, J.P. Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: A basic science study. Arthritis Res. Ther. 2007, 9, R121:1-R121:10.
134. Amiable, N.; Tat, S.K.; Lajeunesse, D.; Duval, N.; Pelletier, J.P.; Martel-Pelletier, J.; Boileau, C. Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts. Bone 2009, 44, 1143-1150.